https://www.selleckchem.com/pr....oducts/4-Methylumbel
We discuss the potential of clinical targeting poly (ADP-ribose) polymerase which might prevent downstream mitochondrial dysfunction and confer protection to cancer survivors. Overall we emphasize the importance of recognizing the consequences of cardio-toxic effects of several cancer treatments and therefore developing personalized therapeutic approaches to screen for inflammatory and cardiac testing for better patient survival.Venous thromboembolic disease (VTE) is a common complication among patients with cancer.
Like
Comment
Share
